- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04480515
Does COVID-19 Pandemic Reduce In-hospital Mortality?
July 17, 2020 updated by: Ramazan Guven, Kanuni Sultan Suleyman Training and Research Hospital
COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world.
Although it is suggested that hospital admissions are reduced due to some reasons such as trauma, during COVID-19 pandemic, it is controversial whether in-hospital mortality rates changed.
Therefore this multi-centered study aimed to determine how in-hospital mortality effected during the pandemic period according to the specific patient groups.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world.
Although it is suggested that hospital admissions are reduced due to some reasons such as trauma, during COVID-19 pandemic, it is controversial whether in-hospital mortality rates changed.
Therefore this multi-centered study aimed to determine how in-hospital mortality effected during the pandemic period according to the specific patient groups.
Thus, in case of a pandemic, it will be a guide in which patient groups healthcare providers should be more careful about.
Study Type
Observational
Enrollment (Actual)
5000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34303
- Kanuni Sultan Suleyman Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All the records of in-hospital mortality will be evaluated
Description
Inclusion Criteria:
- Deaths, with all required data available, occurred within the study hospitals
- centers Accepted to participate with an informed consent
Exclusion Criteria:
- lack of consent
- lack of data
- deaths occurred outside the study hospitals
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
In-hospital mortality
Time Frame: 4 months
|
During the pandemic (March-July), deaths occurred in hospital will be evaluated.
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 11, 2020
Primary Completion (Actual)
June 15, 2020
Study Completion (Actual)
June 30, 2020
Study Registration Dates
First Submitted
July 17, 2020
First Submitted That Met QC Criteria
July 17, 2020
First Posted (Actual)
July 21, 2020
Study Record Updates
Last Update Posted (Actual)
July 21, 2020
Last Update Submitted That Met QC Criteria
July 17, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KSSEAH--IHM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on in-hospital mortality rate
-
Shanghai 10th People's HospitalFirst Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern... and other collaboratorsRecruiting
-
Ottawa Hospital Research InstituteThe Hospital for Sick Children; Hopital Montfort; Unity Health Toronto; The Ottawa... and other collaboratorsEnrolling by invitationImplementation Science | Screening | Terminal Care | Palliative TherapyCanada
-
Uşak UniversityCompleted
-
Uşak UniversityRecruitingDiabetes Mellitus | Covid19Turkey
-
Rafiq OKINECompletedMortality | Feasibility | Safety | Malaria,FalciparumGhana, Kenya, Malawi
-
Swedish Heart Lung FoundationThe Council for Medical Health Care Research in South Sweden; The Malmö University... and other collaboratorsCompleted
-
National University Health System, SingaporeNational University of SingaporeCompleted
-
Centre Hospitalier Universitaire de NīmesCompletedPain | Chronic Pain | Surgical Procedures, OperativeFrance
-
Comité Départemental Olympique et Sportif de Seine...Not yet recruiting